Subscribe

0

  • Sign in with Email

By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.

Don’t have an account? Signup

  • Bookmarks
  • My Profile
  • Log Out
  • NEWS
  • POLICIES
  • MSME OPPORTUNITIES
  • BANKING & FINANCE
  • TECHNOLOGY FOR SMES
  • SECTORS
  • GLOBAL
  • Investment
  • LEGAL
  • KNOWLEDGE QUEST
  • Future Ready Forum 2025
  • Ek Nayi Udaan
  • Future Ready Summit 2024
  • ADVERTISE WITH US
ad_close_btn
  • News
  • Policies
  • Banking & Finance
  • MSME Opportunities
  • Web Stories
  • InFocus
  • Technology For SMEs
  • Sectors
  • Global
  • Fashion

Powered by :

You have successfully subscribed the newsletter.
Banking & Finance Stock Market

Traders Body Appealed SEBI to Restrict PharmEasy's IPO

"The business model of 'PharmEasy' which is controlled by 'API Holdings' is entirely based on gross illegality," the traders' body said in a statement.

author-image
SMEStreet Edit Desk
11 Dec 2021 06:50 IST

Follow Us

New Update
ipo

The Confederation of All India Traders wrote to the Securities and Exchange Board of India urging the marking regulator not to allow e-pharmacy firm PharmEasy's initial public offering.

"The business model of 'PharmEasy' which is controlled by 'API Holdings' is entirely based on gross illegality," the traders' body said in a statement.

Citing a Delhi High Court order passed in 2018, the traders' body said that sale of medicines over the internet is not allowed.

API Holdings, the parent company of the e-pharmacy firm PharmEasy has reportedly filed the 'Draft Red Herring Prospectus' to the market regulator recently.

"We believe that investor wealth worth billions is at stake if this IPO is approved by SEBI. We are sure that it will receive your kind and immediate attention," the statement added.

In addition, the traders' body alleged that the Pharmeasy has mentioned Thyrocare as its subsidiary in the DRHP submitted to the SEBI, without any order from the Competition Commission of India, whcih prevents activities that potentially may have an adverse effect on business.

The South Chemists and Distributors Association had also submitted a letter to the SEBI with requests on the same line.

PharmEasy SEBI CAIT
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news
logo

Related Articles
Read the Next Article
Latest Stories
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news

Latest Stories
Latest Stories
    Powered by


    Subscribe to our Newsletter!




    Powered by
    Select Language
    English

    Share this article

    If you liked this article share it with your friends.
    they will thank you later

    Facebook
    Twitter
    Whatsapp

    Copied!